Skip to main content
Pediatric Rheumatology logoLink to Pediatric Rheumatology
. 2012 Jul 13;10(Suppl 1):A111. doi: 10.1186/1546-0096-10-S1-A111

Hypergammaglobulinemia in the pediatric population

Mindy S Lo 1,, Robert P Sundel 1
PMCID: PMC3403003

Purpose

Hypergammaglobulinemia in adult patients is usually related to malignancy, autoimmune disease, or infection. The differential diagnosis of hypergammaglobulinemia in children has not been similarly well defined. Malignancies and autoimmunity are much less common in children compared to the adult population, and therefore the implications of an elevated immunoglobulin in a pediatric patient are less clear. We therefore sought to establish the differential diagnosis of hypergammaglobulinemia in children through a retrospective cohort analysis.

Methods

The Children’s Hospital Boston laboratory database was queried for all in- and out-patients with IgG levels ≥2000 mg/dL measured from 2000-2009. Charts were reviewed and patient characteristics, associated laboratory findings, diagnoses and outcomes were extracted. A random sampling of 10% of the patients was analyzed in detail.

Results

A total of 1519 instances of IgG levels ≥2000 mg/dL belonging to 748 individual patients were identified. Of these, 85 patients were analyzed in detail. Thirty-one (36.5%) were excluded because they had received IVIG within one month prior to the abnormal test result. Indications for IVIG included Kawasaki disease (18 cases), immunodeficiency (3 cases), and autoimmune conditions (6 cases, including 2 patients who had received IVIG after rituximab-induced hypogammaglobulinemia). Among the remaining 54 patients who had not received IVIG, autoimmune/autoinflammatory conditions comprised the largest group (25 patients, 46.3%); cystic fibrosis was next most frequent (13 cases, 24.1%), followed by acute infection (9 patients, 16.7%) and malignancy (3 patients, 5.6%). The most frequent rheumatologic conditions were lupus (7 patients, 13.0%; 5 with SLE, 1 discoid lupus, and 1 minocycline-induced lupus), polyarticular JIA (4 cases, 7.4%) and MCTD (2 cases, 3.7%). Among infectious conditions, 6 patients had acute bacterial infections while 3 patients were presumed to have a self-limited viral process.

Table 1.

Disease categories presenting with hypergammaglobulinemia

Diagnosis Mean IgG Meadian IgG Number (%)
Autoimmunity 2458 2200 25 (46.3)
Lupus/SLE 2693 2400 7 (13.0)
Poly JIA 2321 2337 4 (7.4)
MCTD 2230 2230 2 (3.7)
Cystic fibrosis 2147 2120 13 (24.1)
Infection 2554 2330 9 (16.7)
Malignancy 2512 2188 3 (5.6)

Conclusion

Among a cohort of patients at a large tertiary care children’s hospital with IgG level ≥2000 mg/dL, rheumatologic conditions constituted a much more frequent cause than infections. A wide variety of autoimmune diseases were represented, although not surprisingly lupus was the most frequent diagnosis. Interestingly, our cohort also included a large number of cystic fibrosis patients. The reason for hypergammaglobulinemia in many patients is not clear, though further studies may allow distinction between endogenous and exogenous lymphocyte stimulation.

Disclosure

Mindy S. Lo: None; Robert P. Sundel: None.


Articles from Pediatric Rheumatology Online Journal are provided here courtesy of BMC

RESOURCES